HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by GraniteShares Advisors LLC

GraniteShares Advisors LLC lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 5.7% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 771 shares of the company’s stock after selling 47 shares during the quarter. GraniteShares Advisors LLC’s holdings in HCA Healthcare were worth $234,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Covestor Ltd raised its stake in shares of HCA Healthcare by 122.7% during the 1st quarter. Covestor Ltd now owns 167 shares of the company’s stock worth $42,000 after buying an additional 92 shares during the last quarter. Fortis Capital Advisors LLC acquired a new position in HCA Healthcare during the 4th quarter worth approximately $48,000. BDO Wealth Advisors LLC lifted its position in HCA Healthcare by 60.0% during the 2nd quarter. BDO Wealth Advisors LLC now owns 160 shares of the company’s stock worth $49,000 after acquiring an additional 60 shares in the last quarter. Cutler Group LLC CA lifted its position in HCA Healthcare by 566.7% during the 1st quarter. Cutler Group LLC CA now owns 200 shares of the company’s stock worth $52,000 after acquiring an additional 170 shares in the last quarter. Finally, WASHINGTON TRUST Co lifted its position in HCA Healthcare by 100.0% during the 2nd quarter. WASHINGTON TRUST Co now owns 180 shares of the company’s stock worth $55,000 after acquiring an additional 90 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Up 1.5 %

Shares of NYSE HCA opened at $241.04 on Thursday. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $304.86. The company has a market cap of $64.52 billion, a price-to-earnings ratio of 11.86, a P/E/G ratio of 1.32 and a beta of 1.66. The company has a quick ratio of 0.99, a current ratio of 1.15 and a debt-to-equity ratio of 103.06. The business has a fifty day simple moving average of $243.49 and a 200-day simple moving average of $267.04.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $3.91 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.97 by ($0.06). The business had revenue of $16.21 billion during the quarter, compared to analysts’ expectations of $15.77 billion. HCA Healthcare had a return on equity of 2,040.32% and a net margin of 9.05%. Sell-side analysts predict that HCA Healthcare, Inc. will post 18.18 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 28th. Stockholders of record on Thursday, December 14th will be paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date is Wednesday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.81%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on HCA. Sanford C. Bernstein cut their target price on HCA Healthcare from $345.00 to $294.00 in a research report on Tuesday, October 10th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $315.00 target price on shares of HCA Healthcare in a research report on Thursday, September 14th. Oppenheimer upped their price target on HCA Healthcare from $310.00 to $315.00 and gave the company an “outperform” rating in a research report on Friday, July 28th. Wells Fargo & Company dropped their price target on HCA Healthcare from $267.00 to $254.00 and set an “equal weight” rating on the stock in a research report on Thursday, October 26th. Finally, StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, November 1st. Two research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $297.41.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.